STOCK TITAN

Acrivon Therapeutics, Inc. (ACRV) Net Income by Year

ACRV

Acrivon Therapeutics, Inc. reported a net loss of $77.9M in fiscal year 2025. This represents an increase of 3.3% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Acrivon Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income -$77.9M
YoY +3.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ACRV Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-K
Net Income-$77.9M+3.3%-$80.6M-33.4%-$60.4M-93.8%-$31.2M-91.9%-$16.2M

ACRV Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$18.0M+14.5%-$19.0M+3.2%N/A-$18.2M+18.7%-$21.0M-11.7%-$19.7M-19.4%N/A-$22.4M-55.1%-$18.8M-35.1%-$16.5M-29.2%N/A-$14.5M-57.3%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Acrivon Therapeutics, Inc. financials

Frequently Asked Questions

What was Acrivon Therapeutics, Inc.'s net income in fiscal year 2025?

Acrivon Therapeutics, Inc. reported a net loss of $77.9M in fiscal year 2025.

How fast is Acrivon Therapeutics, Inc.'s net income growing?

Acrivon Therapeutics, Inc. (ACRV) net income rose by 3.3% year over year, from -$80.6M to -$77.9M in fiscal year 2025.

How has Acrivon Therapeutics, Inc.'s net income changed over the years?

Across the 5 fiscal years this page covers, Acrivon Therapeutics, Inc. (ACRV) net income went from -$16.2M in fiscal year 2021 to -$77.9M in fiscal year 2025.

Acrivon Therapeutics, Inc. (ACRV) reported -$18.0M in net income in Q2 2026. This represents an increase of 14.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Acrivon Therapeutics, Inc. (ACRV) reported on that line in every period on record.